Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (71-80 of 342) with videos related to

Pageof 35
Sort By:
Cancer|August 6, 2013
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Leukemia Research|July 2, 2013
Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studiesSamir Dalia, Julio Chavez, Jorge J Castillo, et al.
JAMA Oncology|February 3, 2018
Fitting mSMART Into the Current Clinical Management of Waldenström MacroglobulinemiaJorge J Castillo, Joshua N Gustine, Steven P Treon
Cells|October 27, 2022
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström MacroglobulinemiaJavier Muñoz, Jonas Paludo, Shayna Sarosiek, et al.
Hematology/Oncology Clinics of North America|August 13, 2023
Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström MacroglobulinemiaMark Bustoros, Caitlin Gribbin, Jorge J Castillo, et al.
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative DisordersJorge J Castillo, Steven P Treon, Matthew S Davids
American Journal of Hematology|March 26, 2016
Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphomaCarolina Marini, Helena Baldaia, Fernanda Trigo, et al.
American Journal of Hematology|September 30, 2017
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomasAdam J Olszewski, John L Reagan, Jorge J Castillo
Leukemia Research|July 24, 2014
Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studiesEmmanuel Apor, Jennifer O'Brien, Merin Stephen, et al.
Cancer Treatment and Research|February 7, 2015
Biology, prognosis, and therapy of Waldenström MacroglobulinemiaJorge J Castillo, Irene M Ghobrial, Steven P Treon
Pageof 35

Showing results (71-80 of 342) with videos related to

Sort By:
Pageof 35
Cancer|August 6, 2013
Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results databaseJorge J Castillo, Eric S Winer, Adam J Olszewski
Leukemia Research|July 2, 2013
Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studiesSamir Dalia, Julio Chavez, Jorge J Castillo, et al.
JAMA Oncology|February 3, 2018
Fitting mSMART Into the Current Clinical Management of Waldenström MacroglobulinemiaJorge J Castillo, Joshua N Gustine, Steven P Treon
Cells|October 27, 2022
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström MacroglobulinemiaJavier Muñoz, Jonas Paludo, Shayna Sarosiek, et al.
Hematology/Oncology Clinics of North America|August 13, 2023
Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström MacroglobulinemiaMark Bustoros, Caitlin Gribbin, Jorge J Castillo, et al.
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative DisordersJorge J Castillo, Steven P Treon, Matthew S Davids
American Journal of Hematology|March 26, 2016
Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphomaCarolina Marini, Helena Baldaia, Fernanda Trigo, et al.
American Journal of Hematology|September 30, 2017
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomasAdam J Olszewski, John L Reagan, Jorge J Castillo
Leukemia Research|July 24, 2014
Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studiesEmmanuel Apor, Jennifer O'Brien, Merin Stephen, et al.
Cancer Treatment and Research|February 7, 2015
Biology, prognosis, and therapy of Waldenström MacroglobulinemiaJorge J Castillo, Irene M Ghobrial, Steven P Treon
Pageof 35